Provectus Biopharmaceuticals (PVCT) Current Assets (2010 - 2026)
Provectus Biopharmaceuticals' Current Assets came in at $1.37 million for Q2 2026, up 140.9% from $568,320 a year earlier.
Powered by 
Analysis
Provectus Biopharmaceuticals (PVCT) Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Provectus Biopharmaceuticals' Current Assets was $567,874, down 41.9% from FY2024.
- Current Assets has declined in each of the last four years, though with a five-year compound annual growth rate of 6.0% (FY2020 to FY2025).
- Going back by year, Current Assets was $976,772 in FY2024 (-28.4%), $1.36 million in FY2023 (-28.1%), $1.9 million in FY2022 (-44.8%) and $3.44 million in FY2021 (+712.4%).
- The Q2 2026 figure represents the highest quarterly Current Assets since Q3 2023.
- Year-over-year, Current Assets increased in 1 of the last seven quarters, with an average decline of 15.7%.
- The fastest year-over-year change in Current Assets over five years came in Q4 2021 (growth of 712.4%), and the weakest in Q3 2025 (a decline of 63.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Provectus Biopharmaceuticals | 21.01 Mn | 19.10 Mn | - | 1.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.37 Mn |
| Dec 31, 2025 | 567,874.00 |
| Sep 30, 2025 | 277,988.00 |
| Jun 30, 2025 | 568,320.00 |
| Mar 31, 2025 | 649,469.00 |
| Dec 31, 2024 | 976,772.00 |
| Sep 30, 2024 | 760,003.00 |
| Jun 30, 2024 | 800,244.00 |
| Mar 31, 2024 | 1.01 Mn |
| Dec 31, 2023 | 1.36 Mn |
| Sep 30, 2023 | 1.59 Mn |
| Jun 30, 2023 | 1.58 Mn |
| Mar 31, 2023 | 1.60 Mn |
| Dec 31, 2022 | 1.90 Mn |
| Sep 30, 2022 | 1.90 Mn |
| Jun 30, 2022 | 2.28 Mn |
| Mar 31, 2022 | 2.71 Mn |
| Dec 31, 2021 | 3.44 Mn |
| Sep 30, 2021 | 506,548.00 |
| Jun 30, 2021 | 347,221.00 |
API Access
Provectus Biopharmaceuticals Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=PVCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "PVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=PVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();